Nobelium GoodLeap Co-Invest 2026 Blocker, LLC has made a significant move by filing a new offering with the SEC, raising a total of $41.72 million. This development is notable as it reflects the company's ability to attract investment in the competitive landscape of private equity.
The filing, dated November 3, 2026, reveals that the entire offering amount has been sold, with four investors already participating. This indicates a strong level of interest and confidence in the company's investment strategy.
Background
Nobelium GoodLeap Co-Invest 2026 Blocker, LLC is a limited liability company incorporated in Delaware, with its business address located at 590 Pacific Avenue, San Francisco, California. The company operates in the pooled investment fund sector, specifically focusing on private equity investments.
The recent filing is categorized under Form D, which is typically used for reporting exempt offerings of securities under the 1933 Act. The company has not disclosed its SIC code or specific industry details in the filing.
What the Filing Says
The SEC filing states that the offering is made under Rule 506(b), which provides a safe harbor for private offerings. It also notes that the total offering amount raised is $41.72 million, with no remaining balance left to sell.
“The total amount sold is $41.72 million,” the filing indicates.
Impact
This successful offering may have implications for both investors and the broader private equity market. With four investors already on board, it suggests that there is a growing appetite for investments in pooled funds, particularly those focusing on private equity ventures.
What's Next
The filing does not specify what happens next for Nobelium GoodLeap Co-Invest 2026 Blocker, LLC. However, the completion of this offering positions the company to potentially pursue new investment opportunities or expand its current portfolio.
Read Next
JPMorgan Chase Financial Co. files pricing supplement for $84M
JPMorgan Chase Financial Co. updates prospectus on equity index
Bank of Nova Scotia offers $3 million in new notes
Magrath George files to sell shares of Opus Genetics, Inc.
JPMorgan Chase Financial Co. files pricing supplement for notes
nCino Officer Sells Over 29,000 Shares Amid Market Activity




